Skip to search.
 FTSE 100 Down 0.03%

More On BTG.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

BTG plc (BTG.L)

-LSE Ticker: 100159/ISIN: GB0001001592
645.00 Up 4.50(0.78%) 23 Sep 17:09
Prev Close:640.50
Open:636.00
Bid:N/A x 66000
Ask:N/A x 112600
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:634.50 - 645.50
52wk Range:504.00 - 739.50
Volume:1,325,946
Avg Vol (3m):660,841
Market Cap:2.47b
P/E (ttm):41.35
EPS (ttm):15.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):550,987.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback